|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| A61K 39/395 | |||
| A61K 31/551 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 2850104 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13790467.8 |
| Date of filing the European patent application | 2013-05-15 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/041209 |
| Date | 2013-05-15 |
| (87) | Number | WO 2013/173496 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261649110 P | 2012-05-18 | US | |
| 201313804227 | 2013-03-14 | US |
| (72) |
SUTHERLAND, May Kung, US
RYAN, Maureen, US
SUSSMAN, Django, US
BURKE, Patrick, US
JEFFREY, Scott, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER |
| CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER |